4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-049478
Chief Financial Officer sold 50,000 shares at an average $8.56 ($427,950)
- Chief Financial Officer acquired 75,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Secora Michael · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +37,500 | $2.22 | $83,250 | 900,686 | D |
| 2023-09-12 | Sale : show line 2 in the form 10b5-1 | −25,000 | $8.43 | $210,633 | 875,686 | D |
| 2023-09-13 | Exercise or conversion : show line 3 in the form 10b5-1 | +37,500 | $2.22 | $83,250 | 913,186 | D |
| 2023-09-13 | Sale : show line 4 in the form 10b5-1 | −25,000 | $8.69 | $217,318 | 888,186 | D |
| Open-market sales · 50,000 sh · avg $8.56 · $427,950 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −37,500 | $2.22 | 2030-03-03 | 37,500 | 1,372,635 | D |
| 2023-09-13 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −37,500 | $2.22 | 2030-03-03 | 37,500 | 1,335,135 | D |
Loading xslF345X05/doc4.xml…